Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
Clinical trial NCT01847430 · COMPLETED
Trial details
- NCT number
- NCT01847430
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-19
- Primary completion
- 2014-02-21
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.